Verma Abhimanyu sold $38K of SOPH
Verma Abhimanyu (Chief Technology Officer) sold 6,944 shares of SOPHiA GENETICS SA (SOPH) at $5.51 on 2026-06-25 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure provides transparency on insider trading activity but does not include new operational, financial, or regulatory developments for SOPH.
Market read
Traders may note the insider sale, but the 10b5-1 structure and modest dollar amount make it unlikely to drive a sustained repricing.
What to watch
The filing does not state reasons for sale, and the post-transaction holdings (197,456 shares) suggest the insider did not exit the position.
Background
The article is an SEC Form 4 insider transaction disclosure for SOPHiA GENETICS SA.
Ticker impact
SOPHiA GENETICS CTO Verma Abhimanyu sold 6,944 shares in an open-market transaction worth $38,229.50 under a 10b5-1 plan.
Likely minimal impact on SOPH price; any effect is typically short-lived and outweighed by broader company-specific catalysts.
The filing is a Form 4 insider transaction, but it is explicitly under a pre-arranged 10b5-1 plan and the disclosed value is relatively small versus typical market-moving thresholds.
Market effects
No clear sector read-through from a single, small 10b5-1 insider sale.
None indicated.
None indicated.
Counterpoint
Insider sales can still reflect private information, but the presence of a 10b5-1 plan reduces the informational edge.
Key entities
- issuerSOPHiA GENETICS SA
Company whose insider transaction was reported on Form 4.
- insiderVerma Abhimanyu
Chief Technology Officer who sold shares under a 10b5-1 plan.
